Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dawnrays Pharmaceutical Holdings Ltd

2348
Current price
1.25 HKD +0.02 HKD (+1.63%)
Last closed 1.25 HKD
ISIN KYG2687M1006
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Exchange Hong Kong Stock Exchange
Capitalization 1 877 329 244 HKD
Yield for 12 month +15.74 %
1Y
3Y
5Y
10Y
15Y
2348
21.11.2021 - 28.11.2021

Dawnrays Pharmaceutical (Holdings) Limited, an investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally. It operates in two segments, Intermediates and Bulk Medicines, and Finished Drugs. The company offers antibiotics, including pharmaceutical intermediates, bulk medicines, powder for injections, and oral antibiotics. It also provides and system specific medicines comprising cardiovascular systems; anti-allergic, anti-HBV, and digestive systems; urinary systems; and anti-pyretic analgesic, respiratory, and endocrine system drugs in the form of tablets, capsules, and granules. Dawnrays Pharmaceutical (Holdings) Limited was founded in 1995 and is headquartered in Wan Chai, Hong Kong. Address: CNT Tower, Wan Chai, Hong Kong

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

21.4 HKD

P/E ratio

3.0488

Dividend Yield

6.38 %

Current Year

+1 242 383 067 HKD

Last Year

+1 378 949 205 HKD

Current Quarter

+540 951 355 HKD

Last Quarter

+701 431 704 HKD

Current Year

+692 364 853 HKD

Last Year

+827 443 776 HKD

Current Quarter

+294 028 876 HKD

Last Quarter

+384 262 447 HKD

Key Figures 2348

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 313 424 234 HKD
Operating Margin TTM 24.97 %
PE Ratio 3.0488
Return On Assets TTM 3.77 %
PEG Ratio
Return On Equity TTM 18.41 %
Wall Street Target Price 21.4 HKD
Revenue TTM 1 079 709 680 HKD
Book Value 2.18 HKD
Revenue Per Share TTM
Dividend Share 0.073 HKD
Quarterly Revenue Growth YOY -11.2 %
Dividend Yield 6.38 %
Gross Profit TTM 767 415 543 HKD
Earnings per share
Diluted Eps TTM
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY 92.8 %
Profit Margin 52.2 %

Dividend Analytics 2348

Dividend growth over 5 years

-35 %

Continuous growth

3 years

Payout Ratio 5 years average

35 %

Dividend History 2348

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 0.08
Ex Dividend Date 16.09.2024
Forward Annual Dividend Yield 6.4 %
Last Split Factor 2:1
Payout Ratio 19.48 %
Last Split Date 06.08.2018
Dividend Date

Stock Valuation 2348

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 3.0488
Forward PE
Enterprise Value Revenue 0.6344
Price Sales TTM 1.7387
Enterprise Value EBITDA 0.9292
Price Book MRQ 0.5298

Financials 2348

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators 2348

For 52 weeks

0.93 HKD 1.4 HKD
50 Day MA 1.2 HKD
Shares Short Prior Month
200 Day MA 1.19 HKD
Short Ratio
Shares Short
Short Percent